Literature DB >> 2565339

Structure of the human gene for the proliferating cell nuclear antigen.

S Travali1, D H Ku, M G Rizzo, L Ottavio, R Baserga, B Calabretta.   

Abstract

The proliferating cell nuclear antigen (PCNA, cyclin) was originally defined as a nuclear protein whose appearance correlated with the proliferative state of the cell. It is now known to be a co-factor of DNA polymerase delta and to be necessary for DNA synthesis and cell cycle progression. cDNA clones of human PCNA have been isolated and, using one of these cDNA, we have now obtained from a lambda phage library a clone containing the entire human PCNA gene and flanking sequences. The human PCNA gene is a unique copy gene and has 6 exons. It spans, from the cap site to the poly(A) signal 4961 base pairs. We have identified, in the 5'-flanking sequence, a region with promoter activity, a well as other structural elements common to other promoters. An interesting feature of the PCNA gene is the presence of extensive sequence similarities among introns and between introns and exons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565339

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins.

Authors:  Isabelle Gaudreault; David Guay; Michel Lebel
Journal:  Nucleic Acids Res       Date:  2004-01-12       Impact factor: 16.971

2.  The role of the promoter in the expression of the PCNA gene.

Authors:  R H Charollais; H Alder; A Ferber; J Koniecki; C Sell; R Baserga
Journal:  Gene Expr       Date:  1992

3.  Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.

Authors:  A S Perkins; R Fishel; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

4.  Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Xiaoyan Wang; Robert J Hickey; Linda H Malkas; Michael O Koch; Lang Li; Shaobo Zhang; George E Sandusky; David J Grignon; John N Eble; Liang Cheng
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

5.  Upstream sequences of rice proliferating cell nuclear antigen (PCNA) gene mediate expression of PCNA-GUS chimeric gene in meristems of transgenic tobacco plants.

Authors:  S Kosugi; I Suzuka; Y Ohashi; T Murakami; Y Arai
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

6.  Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.

Authors:  O W Kamel; D P LeBrun; R E Davis; G J Berry; R A Warnke
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

7.  Identification and functional analysis of PCNA1 and PCNA-like1 genes of Phaseolus coccineus.

Authors:  Wojciech Strzalka; Anna Kaczmarek; Barbara Naganowska; Alicja Ziemienowicz
Journal:  J Exp Bot       Date:  2009-12-10       Impact factor: 6.992

8.  Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.

Authors:  U Zeymer; M C Fishbein; J S Forrester; B Cercek
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

9.  Molecular characterisation and stage-specific expression of proliferating cell nuclear antigen (PCNA) from the malarial parasite, Plasmodium falciparum.

Authors:  B J Kilbey; I Fraser; S McAleese; M Goman; R G Ridley
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

10.  A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.

Authors:  C Labrie; G F Morris; M B Mathews
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.